Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)

SHE:300204 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	9,766	13,053	3,540	4,854	6,419	8,242
Market Cap Growth	-39.26%	268.69%	-27.07%	-24.38%	-22.12%	94.35%
Enterprise Value	9,786	12,926	3,498	4,711	6,113	7,806
Last Close Price	20.44	27.32	7.41	10.16	13.60	17.55

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Forward PE	-	16.49	16.49	16.49	16.49	16.49
PS Ratio	52.07	59.27	10.90	13.33	11.69	14.11
PB Ratio	12.35	16.18	3.86	4.76	4.74	5.32
P/TBV Ratio	15.25	17.07	4.05	5.03	5.12	5.70

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
EV/Sales Ratio	52.18	58.69	10.77	12.94	11.14	13.36

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Debt / Equity Ratio	0.21	0.12	0.05	0.04	0.02	0.01
Net Debt / Equity Ratio	0.05	-0.04	-0.01	-0.04	-0.17	-0.30
Net Debt / EBITDA Ratio	-0.59	0.51	0.53	0.13	1.17	2.23
Net Debt / FCF Ratio	-0.19	0.15	0.13	0.17	1.02	2.10
Asset Turnover	0.15	0.18	0.26	0.24	0.31	0.32
Inventory Turnover	2.51	2.42	2.89	3.75	4.64	3.69
Quick Ratio	1.15	0.95	0.61	0.71	1.96	3.18
Current Ratio	1.73	1.44	1.15	1.15	2.28	3.50
Return on Equity (ROE)	-10.62%	-10.22%	-15.25%	-33.60%	-13.56%	-8.76%
Return on Assets (ROA)	-4.24%	-4.30%	-2.23%	-15.57%	-8.36%	-8.13%
Return on Invested Capital (ROIC)	-10.71%	-9.89%	-4.71%	-35.70%	-21.17%	-23.89%
Return on Capital Employed (ROCE)	-7.50%	-7.60%	-4.50%	-33.30%	-16.30%	-14.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Earnings Yield	-0.92%	-0.60%	-4.09%	-8.22%	-3.07%	-1.67%
FCF Yield	-1.98%	-1.55%	-2.46%	-5.37%	-3.62%	-2.65%
Buyback Yield / Dilution	15.87%	-0.66%	-1.67%	1.17%	-1.42%	0.27%
Total Shareholder Return	15.87%	-0.66%	-1.67%	1.17%	-1.42%	0.27%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 30, 2026

Data Sources Report a data error